
Evaluation of lipoprotein (a) [Lp(a)] and lipid abnormalities in patients with newly detected hypertension and its association with severity of hypertension
Author(s) -
SubodhKumar Mahto,
Ankita Sheoran,
Adeshkisanji Gadpayle,
Kritika Gupta,
PulinKumar Gupta,
Anubhuti Chitkara,
Nidhi Agarwal
Publication year - 2022
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_989_21
Subject(s) - medicine , lipoprotein(a) , microalbuminuria , blood pressure , left ventricular hypertrophy , lipoprotein , gastroenterology , cardiology , disease , diastole , complications of hypertension , endocrinology , cholesterol
Hypertension remains the major preventable cause of cardiovascular disease (CVD). Lipoprotein (a) is seen to be associated with established essential hypertension and contributes to atherogenesis or to thrombogenesis or both.